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ABSTRACT
OBJECTIVE: To identify factors associated to medicine use among children 
from the 2004 Pelotas Birth Cohort, Brazil.
METHODS: Prospective study to evaluate medicine use in children aged 3, 
12 and 24 months regardless of the reasons, therapeutic indication or class. 
The study included 3,985 children followed up at three months of age, 3,907 
at 12 months, and 3,868 at the last follow-up time of 24 months. Mothers 
were interviewed to collect information on medicine use during the recall 
period of 15 days prior to the interview. The outcome was studied according 
to sociodemographic and perinatal variables, mother’s perception of child’s 
health and breastfeeding status. Crude and adjusted analyses were performed 
by Poisson regression following a hierarchical model.
RESULTS: The prevalence of medicine use ranged from 55% to 65% in the 
three follow-ups. After controlling for confounders, some variables remained 
associated to medicine use only at the three-month follow-up with greatest 
use among children of younger mothers, those children who had intrapartum 
complications, low birthweight, were never breastfed and were admitted to 
a hospital. Greatest medicine use was also associated with being a fi rstborn 
child at 3 and 12 months; mother’s perception of their child health as fair or 
poor and children whose mothers have private health insurance at 12 and 24 
months; highest maternal education level at all follow-up times.
CONCLUSIONS: Different variables infl uence medicine use among children 
during the fi rst two years of life and they change as the child ages especially 
maternal factors and those associated to the child’s health problems.
DESCRIPTORS: Infant. Child. Drug Utilization. Risk Factors. Maternal 
and Child Health. Cohort Studies.
Artigos Originais
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Medicine use among children is affected by many 
factors that change widely, and frequently social 
concerns outweigh medical reasons.22 Medicines 
play a major role in health and understanding use 
patterns to prevent irrational use is a major goal of 
pharmacoepidemiology.1
Studies on medicine use among children carried out 
in the 1980s and 1990s in the UK showed that most 
mothers (96%) reported their children used some medi-
cine during their fi rst six months of life.17 A study from 
the Netherlands reported that nearly 10% of children 
used at least one medicine in the fi rst month of life and, 
by the age of two, the proportion increased to 81%.25 
In Southern Brazil, an epidemiological study showed 
that medicine use during the fi rst three months of life 
is very frequent with a prevalence higher than 65% 
and long-term use (one month or longer) was reported 
by 20% of mothers. The factors associated to higher 
RESUMO
OBJETIVO: Identifi car fatores associados ao uso de medicamentos nas crianças 
da coorte de nascimentos de 2004 de Pelotas, RS.
MÉTODOS: Estudo de delineamento prospectivo, utilizando como desfecho o 
uso de medicamentos pelas crianças aos três, 12 e 24 meses (independentemente 
do motivo, indicação ou grupo terapêutico). O estudo inclui 3.985 crianças 
no seguimento aos três meses, 3.907 no de 12 meses e 3.868 no último 
seguimento aos 24 meses. Foi realizada entrevista com as mães, referente ao 
uso de medicamento durante período recordatório de 15 dias anteriores. O 
desfecho foi analisado de acordo com variáveis sociodemográfi cas, perinatais, 
da percepção materna de saúde da criança e de amamentação. Foram realizadas 
análises bruta e ajustada utilizando regressão de Poisson e seguindo um modelo 
hierarquizado de análise.
RESULTADOS: A prevalência do uso de medicamentos variou entre 55% e 65% 
nos três seguimentos. Após análise ajustada, algumas variáveis permaneceram 
associadas ao uso de medicamentos apenas no acompanhamento dos três meses, 
com maior utilização entre as crianças com mães mais jovens, quando houve 
algum problema de saúde no momento do parto, baixo peso ao nascer, nas 
crianças que nunca mamaram e quando houve internação hospitalar da criança. 
Também se associou ao maior uso de medicamentos: aos três e 12 meses o 
fato de ser primogênito; aos 12 e 24 meses a percepção de saúde da criança 
pela mãe como regular ou ruim e o fato de a mãe possuir plano de saúde; e 
nos três acompanhamentos, a maior escolaridade das mães.
CONCLUSÕES: Variáveis diferentes infl uenciam a utilização de medicamentos 
nos primeiros dois anos de vida em função do avanço da idade da criança, 
sobretudo fatores associados à mãe da criança e a problemas de saúde da 
criança.
DESCRITORES: Lactente. Criança. Uso de Medicamentos. Fatores de 
Risco. Saúde Materno-Infantil. Estudos de Coortes.
INTRODUCTION
medicine use included: high income; fi rstborn child; 
high number of medical visits; hospitalization; and 
maternal education level between fi ve to eight years of 
schooling. Higher medicine use was also seen among 
children who were not breastfed.28
Different factors related to family, community and health 
settings infl uence medicine use. At the family level, the 
perception of the need of medicines, conceptions about 
effi cacy (or lack thereof), prices and education level 
contribute to medicine use patterns.16 Medicine use in 
children are associated to sociodemographic character-
istics, health insurance status, child’s age younger than 
fi ve, medical visits in the past days, mothers’ perception 
of their child’s health and health conditions.12,15,21
The present study aimed to identify factors associated 
to medicine use among children from the 2004 Pelotas 
Birth Cohort, Brazil.
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METHODS
The study was based on data from the 2004 Pelotas 
Birth Cohort, Brazil, the third birth cohort study 
conducted in the city of Pelotas, southern Brazil. All 
children born during 2004 in the city’s urban area and 
Jardim América district (municipality of Capão do 
Leão) were enrolled. At the perinatal follow-up all 
information were obtained from the child’s mother. In 
subsequent stages the mother was chiefl y the respon-
dent but the child’s father or carer were sometimes the 
respondents. More methodological details of the study 
can be found elsewhere.5,6
The study outcome was report of medicine use regard-
less of therapeutic indication or class at the three, 12- 
and 24-month follow-up during a 15-day recall period. 
Mothers were asked about their children’s medicine 
use in the past 15 days and then medicine names were 
recorded and prescriptions and packages requested.
The outcomes were analyzed according to demo-
graphic, socioeconomic and perinatal variables along 
with breastfeeding status and mother’s perception of 
their child’s health. Sociodemographic information 
collected were: gender, maternal skin color, maternal 
age (complete years), socioeconomic condition (based 
on the National Economic Index [IEN] for the city of 
Pelotas, in quintiles, where the fi rst quintile represents 
the poorest 20% of the population), maternal educa-
tion level (complete years of schooling), maternal and 
child’s private health insurance (at the age of 12 and 24 
months). The IEN is an index based on 12 asset items 
and schooling of the head of the family. The index was 
developed based on a principal component analysis 
using variables from the 2000 Population Census of the 
Instituto Brasileiro de Geografi a e Estatística (Brazilian 
Institute of Geography and Statistics).4
The perinatal variables included: intrapartum compli-
cations; neonatal intensive care unit (ICU) admission; 
low birthweight (<2500 g); preterm birth (according 
to an algorithm combining the last menstrual period, 
ultrasound scan or the Dubowitz method); being a 
fi rstborn child, type of delivery (vaginal or cesarean); 
child’s hospitalization soon after delivery; and gesta-
tional morbidity (hypertension, diabetes, depression, 
threatened miscarriage, bleeding, vaginal discharge, 
urinary tract infection or other infections during preg-
nancy, according to maternal report). Anemia was not 
included as a gestational morbidity because of its high 
prevalence among pregnant women, which would 
distort the prevalence of the variable as a whole.
Mother’s perception of their child’s health was assessed 
at the follow-ups of 12 and 24 months. Although this 
information is available for the follow-up at 3 months, it 
was not included in the analysis because data was only 
collected in a subsample. Breastfeeding information 
(in months) was also assessed and was categorized at 
three months as never breastfed, quit breastfeeding or 
currently breastfeeding. At the ages of 12 and 24 months 
the categories were: never breastfed, breastfed until the 
age of three months, breastfed up to six months of age, 
and breastfed longer than six months.
Data was entered in EpiInfo 6.013 and analyses were 
performed in STATA 9.0. First, crude analyses were 
carried out (outcomes and independent variables) 
to determine prevalence ratios and 95% confi dence 
intervals. Wald’s tests for heterogeneity and linear 
trend were used to measure associations. Then, a 
multivariable analyses (Poisson regression) was carried 
out,3 following a hierarchical model (Figure).27 The 
Poisson regression aims at controlling for confounders, 
retaining in the model variables presenting association 
between 5% and 20%. All variables are controlled for 
the same hierarchical level and upper levels.
All phases of the study were approved by the 
Research Ethics Committee of the Medical School 
of Universidade Federal de Pelotas (protocol nr. 
4.06.00.006, approved on 20 June 2006 and protocol nr. 
4.06.01.113, approved on 9 March 2005). All interviews 
and examinations were only performed after parents or 
carers signed a written consent form.
Socioeconomic and Demographic 
Variables 
(child’s gender, maternal skin color, 
maternal age, socioeconomic 
condition, maternal education, 
maternal health insurance, child’s 
health insurance)
Perinatal Variables
(intrapartum complications, neonatal 
intensive care admission, low 
birthweight, preterm birth, firstborn 
child, type of delivery, gestational 
morbidity)
Contemporary Variables
(mother’s perception of their child’s 






Figure. Hierarchical model of analysis of medication use in 
children. 2004 Pelotas Birth Cohort, Southern Brazil.
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RESULTS
Of 4,231 live births enrolled in the 2004 Pelotas Birth 
Cohort, the present study included 3,985 children 
followed up at three months of age, 3,907 at 12 months, 
and 3,868 at the last follow-up time of 24 months. 
Excluding deaths, follow-up rates were 95.7%, 94.3% 
and 93.5%, respectively. From the beginning of the 
study up to the 24-month visit, loss and refusal rate 
was 6.5% (274 children).
The prevalence of medicine use in children ranged from 
55% to 65%: 65% at three months (95% CI 63.5;66.5); 
64.4% at 12 months (95% CI 63.5;66.5); and 54.7% at 
24 months (95% CI 53.1;56.2).
Of the 4,231 children from the 2004 Birth Cohort, most 
were male, and their mothers were mostly white, 20–29 
years old with less than eight years of schooling. Around 
two-thirds of the children did not have health insurance, 
13% had intrapartum complications, 6% were admitted 
to a neonatal intensive care unit (ICU), 10% were low 
birthweight, 19% were hospitalized during the fi rst 
year of life and 40% were fi rstborn. Most mothers had 
gestational morbidities, perceived their child’s health as 
“excellent” and 81% attended public hospitals.
The highest rates of medicine use were seen among 
fi rstborn children, delivered by C-section, who were 
admitted to neonatal ICU, born to more educated, 
better-off and white women with health insurance. The 
prevalence ratios are presented in Table 1.
Socioeconomic condition was associated to medicine 
use at all follow-up times in the bivariate analysis, but 
after adjustment the association was no longer signifi -
cant (Table 2).
At three months, the adjusted analysis showed 9% 
higher medicine use among children from white-skin 
(p=0.04) compared to black-skin mothers; children 
from younger mothers (12-19 years) had a 13% 
increased use (p=0.01) compared to children from older 
mothers (36 years or older). Maternal education level 
(12 years or more) was associated to a 7% increase in 
medicine use (p=0.04); intrapartum complications was 
associated to 10% increase (p=0.009); low birthweight 
to 11% increase (p=0.01); fi rstborn child 10% increase 
(p=0.001); gestational morbidity and hospitaliza-
tion 16% and 26% increase, respectively, (p<0.001). 
Breastfeeding was also associated with higher medicine 
use (p<0.001); children who were never breastfed used 
25% more medicines compared to those still breast-
feeding at three months (Table 2).
After the adjusted analysis we found that 12-month-old 
boys had 3% higher medicine use (p=0.03); maternal 
education level had a borderline association (p=0.05); 
maternal health insurance was associated (p=0.02) 
as well as child’s health insurance (p=0.006) with a 
9% increase in medicine use. Being a fi rstborn child 
remained associated (p<0.001) to a 10% increase in 
use; as well as mother’s perception of the child’s health 
(p<0.001). The remaining variables that were associ-
ated at three months were no longer associated at 12 
months (Table 2).
After the adjusted analysis, medicine use was higher 
among 24-month-old children from more educated 
women (p<0.001), the only variable that was associated 
with medicine use at all three follow-up times, and was 
more evident at the follow-up of 24 months. Children 
from mothers with 12 or more years of schooling had 
a 34% higher medicine use compared to mothers with 
lower education; children from mothers with health 
insurance were 13% more likely (p<0.001) to use 
medicine at 24 months; neonatal ICU admission was 
also associated to higher (16%) medicine use (p=0.01) 
as well as C-section (9% increase; p=0.007). Type of 
delivery was only associated to medicine use at 24 
months; gestational morbidity that was not associated 
at 12 months showed a signifi cant (p=0.006) 12% 
increase in medicine use; and mother’s perception 
of the child’s health was strongly associated to the 
outcome (p<0.001). The mother’s perception of the 
child’s health was a strong predictor at 12 and 24 
months and was associated to increased medicine use 
when health was rated as fair (52%) or poor (74%) 
compared to excellent health (Table 2).
DISCUSSION
Cohort studies allow us to understand and to establish 
chronologically facts that are being studied, and to 
observe early characteristics that may infl uence medi-
cine use.28
In our study there was a reduction in the prevalence of 
medicine use over the three follow-up times, especially 
at 24 months. Similar results were found in a 2005 Italian 
study (Lombardia) reporting a prevalence of 65% among 
children from 12 months to fi ve years of age.15 In the 
1982 Pelotas Birth Cohort, the prevalence of medicine 
use was 56% in children aged 35 to 53 months.9
Medicine use throughout the life course shows a 
J-shaped distribution, that is, higher prevalence during 
early life, decreasing during adolescence and gradually 
increasing in adult life with the highest prevalences seen 
among the elderly.2
The factors associated to medicine use in children up to 
two years of age were different from those described in 
adults. Among adults there is a large gender-difference, 
with higher use among women.10,23 In the present study, 
gender was not a determinant of medicine use. Only at 
12 months a slightly higher use was observed among 
boys. Another difference between child and adult use is 
the socioeconomic infl uence. In adults socioeconomic 
condition is a major determinant of medicine use and 
many times it outweighs the actual need with a higher 
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Table 1. Prevalence and crude analysis of factors associated to medicine use at 3, 12 and 24 months of age. 2004 Pelotas Birth 
Cohort, Southern Brazil.
Variable










Gender 0.7* 0.04* 0.2*
Male 64.7 0.99 (0.95;1.04) 65.9 1.05 (1.00;1.10) 55.6 1.04 (0.98;1.10)
Female 65.4 1 62.8 1 53.6 1
Maternal skin color 
(observed by interviewer)
<0.001* 0.002* <0.001*
White 66.8 1.13 (1.06;1.20) 66.0 1.08 (1.02;1.15) 56.6 1.17 (1.08;1.27)
Black 59.1 1 61.1 1 48.3 1
Other 63.6 1.07 (0.97;1.20) 56.5 0.92 (0.82;1.04) 52.8 1.09 (0.96;1.25)
Maternal age (years) 0.2** 0.7** 0.4*
12–19 66.4 1.08 (0.98;1.18) 63.0 1.08 (0.97;1.19) 52.7 1.01 (0.90;1.14)
20–29 65.2 1.07 (0.98;1.16) 64.6 1.10 (1.01;1.20) 55.3 1.06 (0.96;1.18)
30–35 65.5 1.09 (0.99;1.20) 68.0 1.16 (1.06;1.28) 56.0 1.08 (0.96;1.20)




1st 58.1 1 56.0 1 46.4 1
2nd 65.9 1.13 (1.05;1.22) 64.3 1.15 (1.06;1.24) 54.1 1.17 (1.06;1.28)
3rd 66.4 1.14 (1.06;1.23) 64.6 1.15 (1.07;1.25) 56.4 1.21 (1.11;1.33)
4th 67.7 1.17 (1.08;1.26) 68.4 1.22 (1.13;1.32) 58.0 1.25 (1.13;1.38)
5th 69.5 1.20 (1.11;1.29) 72.4 1.29 (1.20;1.39) 61.0 1.31 (1.20;1.44)
Maternal education 
(complete years of 
schooling)
<0.001** <0.001** <0.001**
0–4 59.5 1 57.5 1 43.0 1
5–8 62.7 1.05 (0.98;1.14) 61.3 1.07 (0.99;1.16) 53.2 1.24 (1.11;1.37)
9–11 69.3 1.16 (1.08;1.25) 68.3 1.19 (1.10;1.29) 59.1 1.37 (1.24;1.52)
12 68.4 1.15 (1.05;1.26) 73.8 1.28 (1.17;1.41) 63.9 1.48 (1.32;1.67)
Mother with health 
insurance
<0.001* <0.001* <0.001*
Yes 69.4 1.11 (1.06;1.16) 72.5 1.20 (1.15;1.26) 62.1 1.22 (1.15;1.29)
No 62.8 1 60.4 1 50.9 1
Child with health 
insurance
- <0.001* <0.001*
Yes - 71.9 1.19 (1.14;1.25) 61.0 1.19 (1.12;1.26)
No - 60.2 1 50.8 1
Intrapartum complications <0.001* 0.02* 0.05*
Yes 73.2 1.15 (1.08;1.22) 69.2 1.09 (1.02;1.16) 58.7 1.09 (1.00;1.18)
No 63.9 1 63.7 1 54.1 1
Neonatal ICU admission <0.001* 0.02* 0.002*
Yes 80.3 1.25 (1.16;1.34) 71.1 1.11 (1.01;1.22) 64.1 1.18 (1.06;1.32)
No 64.2 1 64.0 1 54.1 1
Low birthweight (<2500g) <0.001* 0.02* 0.8*
Yes 74.8 1.17 (1.09;1.25) 69.6 1.09 (1.01;1.17) 54.0 1.01 (0.91;1.12)
No 64.0 1 63.9 1 54.7 1
To be continued
492 Factors associated to medicine use in children Oliveira EA et al
use seen among better-off individuals.2,11,19 In our study, 
socioeconomic condition did not affect medicine use at 
any of the follow-up times. Although socioeconomic 
condition was associated to the outcome in the crude 
analysis, after controlling for confounders the effect was 
no longer observed, probably due to maternal education 
level and skin color.
Maternal education was positively associated to medi-
cine use at the three follow-up times and this association 
increased with the child’s age. Another study from 
Pelotas (1982 Birth Cohort) showed that children from 
mothers with more than six years of education used 20% 
more medicines than those whose mothers had less than 
three years of schooling.9 It may be explained by greater 
confi dence and knowledge of these mothers to purchase 
over-the-counter medicines. According to a study about 
inequalities in access and utilization of Brazilian health 
services,18 overall, higher education is associated to a 
better understanding of the health-disease process.
Table 1 continuation
Variable










Preterm birth (according 
to LMP)
0.002* 0.2* 0.5*
Yes 70.1 1.10 (1.04;1.10) 64.3 1 53.9 1
No 63.8 1 66.9 1.04 (0.98;1.11) 55.5 1.03 (0.95;1.11)
Firstborn child <0.001* <0.001* 0.001*
Yes 69.9 1.13 (1.08;1.18) 70.1 1.16 (1.10;1.21) 57.8 1.10 (1.04;1.16)
No 61.9 1 60.6 1 52.6 1
Type of delivery 0.002* <0.001* <0.001*
C-section 67.6 1.07 (1.03;1.12) 68.6 1.13 (1.08;1.18) 59.5 1.18 (1.11;1.24)
Vaginal 62.8 1 60.8 1 50.6 1
Gestational morbidity <0.001* 0.3* 0.01*
Yes 66.5 1.13 (1.06;1.20) 64.8 1.03 (0.97;1.10) 55.6 1.10 (1.02;1.19)
No 59.1 1 62.8 1 50.4 1
Hospitalization <0.001* 0.4* 0.02*
Yes 81.0 1.27 (1.19;1.35) 67.8 1.04 (0.95;1.13) 57.4 1.13 (1.02;1.26)
No 63.9 1 63.6 1 54.4 1
Mother’s perception of 
their child’s healtha
- <0.001** <0.001**
Excellent - - 58.0 1 45.3 1
Very good - - 67.9 1.17 (1.10;1.25) 54.8 1.21 (1.11;1.32)
Good - - 66.8 1.15 (1.09;1.22) 59.1 1.30 (1.21;1.40)
Fair/Poor - - 80.6 1.39 (1.29;1.50) 72.1 1.59 (1.45;1.74)
Breastfeeding (3 months) <0.001** - -
Never breastfed 82.2 1.32 (1.20;1.45) - - - -
Quit breastfeeding 71.2 1.14 (1.09;1.20) - - - -
Currently breastfeeding 62.4 1 - - - -
Breastfeeding (12 and 24 
months)
- 0.6* 0.9*
Never breastfed - - 62.2 0.98 (0.84;1.13) 58.3 1.07 (0.91;1.26)
Breastfeeding up to 3 
months
- - 66.0 1.04 (0.98;1.10) 54.4 1.00 (0.93;1.07)
Breastfeeding 3 to 6 
months
- - 65.1 1.02 (0.96;1.09) 54.7 1.00 (0.93;1.08)
Breastfeeding longer 
than 6 months
- - 63.6 1 54.6 1
ICU: Intensive care unit
IEN: National Economic Index (quintiles for the city of Pelotas)
LMP: Last menstrual period
a Data collected at the follow-up of 12 months, N = 3,907
* Wald’s test for heterogeneity
** Wald’s test for linear trend
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Table 2. Adjusted analysisa of factors associated to medicine use at 3, 12 and 24 months of age. 2004 Pelotas Birth Cohort, Southern 
Brazil.
Variable
3 months 12 months 24 months Level of 
AnalysisbPR (95%CI) p-value PR (95%CI) p-value PR (95%CI) p-value
Gender 0.4* 0.03* 0.1* 1
Male 0.98 (0.94;1.03) 1.05 (1.00;1.10) 1.05 (0.99;1.11)
Female 1 1 1
Maternal skin color (as 
observed by the interviewer) 0.04* 0.09* 0.09* 1
White 1.09 (1.02;1.16) 1.02 (0.96;1.09) 1.10 (1.01;1.19)
Black 1 1 1
Other 1.06 (0.96;1.18) 0.90 (0.80;1.02) 1.07 (0.94;1.23)
Maternal age (complete years) 0.01** 0.1** 0.7* 1
12–19 1.13 (1.07;1.24) 1.13 (1.03;1.26) 1.08 (0.95;1.21)
20–29 1.07 (0.98;1.17) 1.10 (1.01;1.20) 1.06 (0.96;1.18)
30–35 1.06 (0.97;1.17 1.14 (1.04;1.26) 1.06 (0.94;1.18)
36 1 1 1
Socioeconomic level (quintiles 
of IEN) 0.09** 0.06** 0.48** 1
1st 1 1 1
2nd 1.11 (1.03;1.20) 1.11 (1.03;1.20) 1.09 (0.99;1.20)
3rd 1.09 (1.01;1.18) 1.08 (0.99;1.17) 1.11 (1.01;1.23)
4th 1.09 (1.01;1.19) 1.10 (1;1.20) 1.07 (0.96;1.19)
5th 1.09 (1;1.19) 1.11 (1.01;1.22) 1.05 (0.94;1.18)
Maternal education (complete 
(years of schooling) 0.04** 0.05** <0.001** 1
0–4 1 1 1
5–8 1.02 (0.94;1.10) 1.03 (0.95;1.11) 1.22 (1.10;1.36)
9–11 1.09 (1.01;1.18) 1.08 (0.99;1.17) 1.29 (1.16;1.44)
12 1.07 (0.96;1.19) 1.09 (0.97;1.21) 1.34 (1.18;1.53)
Mother with health insurance 0.1* 0.02* <0.001* 1
Yes 1.04 (0.99;1.10) 1.08 (1.01;1.15) 1.13 (1.06;1.21)
No 1 1 1
Child with health insurance - 0.006* 0.3* 1
Yes - 1.09 (1.02;1.16) 1.04 (0.97;1.13)
No - 1 1
Intrapartum complications 0.009* 0.1* 0.9* 2
Yes 1.10 (1.02;1.18) 1.06 (0.98;1.14) 1.01 (0.89;1.14)
No 1 1 1
Neonatal ICU admission 0.2* 0.9* 0.01* 2
Yes 1.08 (0.96;1.22) 1.01 (0.89;1.16) 1.16 (1.03;1.30)
No 1 1 1
Low birthweight (below 2500 g) 0.01* 0.1* 0.2* 2
Yes 1.11 (1.02;1.21) 1.07 (0.99;1.16) 1.07 (0.95;1.20)
No 1 1 1
Preterm birth (according to 
LMP) 0.09* 0.6* 0.6* 2
Yes 1.06 (0.99;1.13) 1 1
No 1 1.02 (0.95;1.09) 1.02 (0.93;1.12)
To be continued
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Maternal age was negatively associated to medicine 
use at three months of age. We did not find any 
studies that evaluated similar associations, however, 
the literature shows that infants fathered by teenagers 
(<20 years old) had an increased risk of preterm birth, 
low birthweight, small-for-gestational-age births, low 
Apgar score, neonatal mortality and post-neonatal 
mortality.14 Considering that teenage parents carry an 
increased risk of adverse birth outcomes, regardless of 
maternal confounders, it is expect greater medicine use, 
especially in early childhood.
Children from white compared to those from black 
mothers had a slightly higher medicine use, and, at 
three months, this association remained after control-
ling for maternal education and socioeconomic 
condition. Similar use patterns were reported in a 
study with children (4-11 years old) from Salvador, 
Northeastern Brazil.24 In another study among adults, 
although the highest prevalence was reported in white 
individuals, skin color was not associated to medicine 
use after adjustment.10
Maternal and/or child’s health insurance positively 
infl uenced medicine use after 12 months of age. This 
fact may be associated to higher access to health care 
services and thus higher number of medical visits.20 Two 
other studies, one from Cataluña (Spain) about factors 
associated to medicine use during childhood,21 and the 
other a Brazilian study,2 showed the same association 
between medicine use and health insurance.
Table 2 continuation
Variable
3 months 12 months 24 months Level of 
AnalysisbPR (95%CI) p-value PR (95%CI) p-value PR (95%CI) p-value
Firstborn child 0.001* <0.001* 0.3* 2
Yes 1.10 (1.04;1.16) 1.10 (1.04;1.16) 1.03 (0.97;1.10)
No 1 1 1
Type of delivery 0.3* 0.06* 0.007* 2
Cesarean 1.02 (0.97;1.08) 1.05 (1.00;1.10) 1.09 (1.02;1.16)
Vaginal 1 1 1
Gestational morbidity <0.001* 0.2* 0.006* 2
Yes 1.16 (1.08;1.24) 1.04 (0.98;1.11) 1.12 (1.03;1.21)
No 1 1 1
Hospitalization <0.001* 1.0* 0.1* 3
Yes 1.26 (1.18;1.35) 1.00 (0.91;1.10) 1.09 (0.99;1.21)
No 1 1 1
Mother’s perception of their 
child’s healthc
- <0.001** <0.001** 3
Excellent - 1 1
Very good - 1.16 (1.09;1.24) 1.18 (1.08;1.29)
Good - 1.23 (1.16;1.30) 1.39 (1.29;1.50)
Fair/Poor - 1.52 (1.40;1.64) 1.74 (1.58;1.91)
Breastfeeding (3 months) <0.001** - - - - 3
Never breastfed 1.25 (1.13;1.38) - -
Quit breastfeeding 1.12 (1.06;1.18) - -
Currently breastfeeding 1 - -
Breastfeeding (12 e 24 months) - - 0.2* 1.0* 3
Never breastfed - 0.88 (0.74;1.04) 1.00 (0.84;1.19)
Breastfeeding up to 3 
months - 1.04 (0.98;1.11) 1.00 (0.92;1.06)
Breastfeeding 3 to 6 months - 1.01 (0.94;1.07) 0.98 (0.91;1.06)
Breastfeeding longer than 6 
months - 1 1
ICU: Intensive care unit
IEN: National Economic Index (quintiles for the city of Pelotas)
LMP: Last menstrual period
a Variables with p-values between 5% and 20% were retained in the model to control for confounders. Those with p-values above 
20% were excluded from the model.
b All variables are controlled for the same level and upper level. 
c Data collected at the follow-up of 12 months, N = 3,907
* Wald’s test for heterogeneity
** Wald’s test for linear trend
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Being a fi rstborn child was associated to higher use 
at three and 12 months of age. The same trend was 
observed in previous birth cohorts from Pelotas (1982 
and 1993), probably due to family’s anxiety and 
concerns about the child’s health.9,28
Different variables directly or indirectly related to more 
severe health conditions (neonatal ICU care, hospital-
ization, low birthweight or gestational conditions), as 
well as the mother’s perception of their child’s health 
were associated to a higher prevalence of medicine use. 
These variables contribute to the understanding of the 
relations found as they all point to the same direction 
and are consistently associated.
A study with 3-month-olds showed that children hospi-
talized in the previous 90 days were more likely to use 
medicines (adjusted OR=2.34).28 Another study showed 
an increased risk of medicine use (PR = 1.98) among 
children (4 to 11 years old) presenting health problems 
in the previous two weeks.24
Higher medicine use among low birthweight children 
is not surprising considering the amount of evidence 
linking low birthweight to health problems throughout 
life, and especially during childhood.7,8 Preterm birth 
was not associated to medicine use after controlling 
for confounders, probably due to simultaneous control 
for low birthweight.
Gestational morbidities may affect child’s health. In a 
study about hypertension and gestational diabetes, two 
of the most prevalent gestational conditions, the authors 
observed that the presence of one or both of these condi-
tions was also associated with adverse consequences 
for the mother and infant (both acute and long-term).26 
Although we did not fi nd any studies associating gesta-
tional morbidities and medicine use among children, 
higher use seen in our study may be explained by health 
problems resulting from gestational morbidities.
The mother’s perception of the child’s health as fair 
or poor was a strong predictor of medicine use, and 
the older the child, the greater this association. It can 
possibly be explained by the same reasons behind 
higher medicine use among children from highly 
educated mothers. This fi nding is in agreement with 
studies carried out in Spain, Brazil and Sweden.10,21,24
At three months, children who were never breastfed 
used 25% more medicines than those who were still 
being breastfed. The 1982 Pelotas Cohort study showed 
that children who were not exclusively breastfed 
were twice more likely to use medicines compared to 
those exclusively breastfed. According to this study, 
mothers exclusively breastfeeding their children are 
apparently more confi dent and less anxious, and their 
children have better health status which would reduce 
medicine use.28
Among the limitations of this study recall bias should 
be considered although the authors sought to overcome 
it by using a 15-day recall period. Potential misinforma-
tion regarding the medicines used by the children based 
on their mothers’ reports was prevented by asking them 
to bring in medicine packages and prescriptions (in the 
three follow-up times, more than 55% of medicines 
packages were shown).
The aspects involving medicine use in children 
discussed here are best understood by socioeconomic, 
perinatal and behavioral characteristics that cannot be 
analyzed separately as they are all linked to the outcome.
Maternal schooling is a factor that can be changed by 
interventions as it infl uences medicine use. Potential 
education interventions among mothers about medicine 
use in children during childhood may promote a more 
rational medicine use in early life.
Epidemiological studies about medicine use in children 
have focused on the investigation of the most used phar-
macological classes and determinants of usage, but little 
has been explored about perinatal characteristics that 
infl uence medicine use during early life. Medicine is an 
important health determinant and to study use patterns 
may help preventing inadequate use among infants.
Different variables infl uence medicine use during the fi rst 
two years of life and it changes as the child grows. Most 
associated factors were somehow related to maternal 
factors and all the remaining were related to child’s health 
problems. Medication use in children is indicated when 
following scientifi c guidelines, but we recognize that, 
especially at younger ages, social concerns may have a 
stronger infl uence than medical reasons.
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